Cell Therapy
Cellino Closes $16M Seed Financing led by The Engine and Khosla Ventures to Automate and Scale Stem Cell Manufacture
What You Should Know: - Cellino, a Cambridge, MA-based personalized regenerative medicine company developing an AI-guided laser editing platform for autologous cell-based therapies, today announced the closing of a $16M Seed financing round. The round was co-led by The Engine and Khosla Ventures, with participation from Humboldt Fund and 8VC. - The company’s platform solves a time-consuming, major bottleneck of developing drugs that rely on cell therapy, having to
Read More
Biofourmis Acquires Digital Therapeutics Oncology Startup Gaido Health
What You Should Know: - Boston-based digital therapeutics startup Biofourmis acquires LA-based Gaido Health from Takeda Pharmaceuticals, in a strategic deal that expands Biofourmis’ portfolio in the oncology space. - Gaido Health—a digital therapeutics company focused on the oncology market—was part of Takeda Digital Ventures, Takeda’s corporate technology investment and incubation arm. - With Gaido Health’s and Biofourmis’ dual focus on remote monitoring with wearables
Read More
Stanford Alumni Scientists, Physicians Launch StartX Med COVID-19 Task Force
What You Should Know: - More than 1500 Stanford faculty and alumni announced the launch of StartX Med COVID-19 Task Force featuring 70+ StartX Med Innovators with medical breakthroughs for the prevention, diagnostics, and treatment of coronavirus mobilize efforts to fast-track public health needs during the pandemic. - The StartX Med COVID-19 Task Force will collaborate on outreach to government agencies, regulatory bodies and healthcare systems in the interest of public health for
Read More
Vineti Raises $33.5M to Accelerate Patient Access to Cell and Gene Therapies
Vineti, Inc., a San Francisco, CA-based software automation and analytics platform for cell and gene therapies has raised $33.5 million in Series B funding led by Canaan and DFJ, with participation from GE Ventures, Section 32, Casdin Capital, and LifeForce Capital, along with other undisclosed investors. The funding round will further advance the first cloud-based “platform of record” specifically built to move transformative new personalized therapies such as CAR-T cell therapy into mainstream
Read More
Mayo Clinic, GE Ventures Partner to Bring IoT Approach to Cell, Gene Therapies
Today, GE Ventures and Mayo Clinic announced they are teaming up to launch Vitruvian Networks, Inc., an independent platform company committed to accelerating access to cell and gene therapies through advanced, cloud-ready software systems and manufacturing services. Vitruvian Networks will partner with therapy producers and serve them by providing a state-of-the-art software and manufacturing platform to bring the Internet of Things (IoT) to cell and gene therapies. At scale, the platform will
Read More
